Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAt the 1.0mg stage of Wegovy, most people have already been on semaglutide for around eight weeks and have cleared the two lower starter doses. Side effects of Wegovy 1.0mg tend to follow a familiar pattern: a temporary flare of nausea or digestive discomfort as your body adjusts to the higher dose, usually settling within one to two weeks. These are prescription-only injections, and a prescriber reviews your full medical picture before any dose step. Knowing what's common, what's manageable at home, and what needs a call to 111 helps you get through the adjustment period with more confidence.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy follows a five-step titration: 0.25mg, 0.5mg, 1.0mg, 1.7mg and 2.4mg, each held for around four weeks before moving up. By the time you reach 1.0mg you've already been on semaglutide for roughly two months, which is long enough to have cleared the initial adjustment period at lower doses. Some people find 1.0mg noticeably more active, appetite suppression sharpens, and the digestive effects that eased off at 0.5mg can return briefly.
That temporary return is normal. Semaglutide slows gastric emptying, which is part of how it reduces hunger, and a step-up in dose means your stomach is working more slowly again while your body catches up. The NHS semaglutide medicines page notes that gastrointestinal effects are the most common side effects across all doses and that they most often improve within a few days to a couple of weeks. Giving the dose a fair chance (rather than stopping at the first uncomfortable day) is usually the right call, but your prescriber is the person to guide that decision for you specifically.
At our Wegovy treatment overview you can read more about how the full dose schedule works and what the titration is designed to achieve.
The Wegovy 1.0mg side effects landscape is dominated by the gastrointestinal group. Nausea tops the list (often described as a background queasiness rather than dramatic illness) followed by diarrhoea, constipation, indigestion, and burping. Vomiting is less common but does happen, particularly in the first week after a dose step. Fatigue, headache and dizziness also appear in trial data, usually mild and short-lived.
A few practical things tend to help: eating smaller portions, avoiding rich or high-fat meals, taking the injection on a day when you're not under pressure, and keeping fluids up. None of that is a substitute for the advice in your patient information leaflet or from your own prescriber, but they're the observations that come up most often. If you'd like a broader picture of what Wegovy side effects can look like across the course of treatment, that page goes into more detail. The general guide to side effects while taking Wegovy covers the management side in more depth.
Some people find 1.0mg is actually smoother than the step to 0.5mg was. Bodies vary, and there's no single experience of this dose. What the trial data from the STEP 1 study (published in the New England Journal of Medicine) consistently showed is that side effects were most pronounced early in treatment and during dose increases, and that the majority were mild to moderate.
Most side effects at this dose are uncomfortable rather than dangerous, but there are specific symptoms that need prompt attention. Severe stomach pain that doesn't ease and radiates through to your back (with or without vomiting) is a warning sign for acute pancreatitis. This is an infrequent but serious side effect; the MHRA highlighted it in a Drug Safety Update in January 2026, reminding patients and clinicians to act quickly. Don't wait for the next routine appointment if this happens.
Call 999 or go to A&E for signs of a serious allergic reaction: swelling of the face, lips, tongue or throat, difficulty breathing, or a widespread rash. Signs of gallbladder problems (sudden pain in the upper right abdomen, nausea and fever together) also need same-day assessment. If you've had a lot of vomiting or diarrhoea and feel dizzy when you stand, dehydration may be a factor: 111 is the right number if you're unsure.
You can also report any suspected side effect, including unexpected ones, to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk. It doesn't take long and it contributes to ongoing post-market safety monitoring for semaglutide, which still carries a Black Triangle (▼) status meaning additional surveillance is in place.
The guide to serious Wegovy side effects covers the warning signs across all doses in more detail.
The 1.0mg dose sits in the middle of the schedule, past the tolerability introductions, short of the maintenance doses where most of the long-term weight data is gathered. One thing worth knowing is that the side effect of Wegovy reported at 1.0mg is very similar in type to those at 0.5mg and 1.7mg. The body's response to semaglutide doesn't transform at each step; intensity may vary but the profile stays consistent.
Contraception is worth flagging here too, though it applies across all doses: the NHS England weight-management injections guidance advises discussing contraceptive methods with your prescriber while on semaglutide. Oral contraceptive absorption may theoretically be affected by delayed gastric emptying, so this is a practical conversation to have rather than an assumption either way.
If you're weighing up how the 1.0mg experience compares to the broader side-effect picture across the full course, the complete Wegovy side effects reference has that wider view. And if you're still deciding whether Wegovy is the right route for you, our prescribers cover suitability and side effects in detail during the consultation, you can start that conversation at our treatment page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.